Showing 1 - 10 of 26
This paper examines the consequences of introducing mobile number portability (MNP). As MNP allows consumers to keep their telephone number when switching providers, it reduces consumers' switching costs. However, MNP may also cause consumer ignorance if telephone numbers no longer identify...
Persistent link: https://www.econbiz.de/10010263405
This paper examines the consequences of introducing mobile number portability (MNP). As MNP allows consumers to keep their telephone number when switching providers, it reduces consumers' switching costs. However, MNP may also cause consumer ignorance if telephone numbers no longer identify...
Persistent link: https://www.econbiz.de/10010315528
Persistent link: https://www.econbiz.de/10002516913
This paper examines the consequences of introducing mobile number portability (MNP). As MNP allows consumers to keep their telephone number when switching providers, it reduces consumers’ switching costs. However, MNP may also cause consumer ignorance if telephone numbers no longer identify...
Persistent link: https://www.econbiz.de/10001744786
Persistent link: https://www.econbiz.de/10001789465
Persistent link: https://www.econbiz.de/10001789550
This paper examines the causes and effects of mobile number portability (MNP) and provides a survey of its implementation in Europe. We first examine the competitive effects and the costs of introducing MNP. Next, we discuss how to charge for MNP. We argue that a price cap regime starting from...
Persistent link: https://www.econbiz.de/10014063401
This paper examines the consequences of introducing mobile number portability (MNP). We show that if the sole effect of introducing MNP is the abolishment of switching costs, MNP unambiguously benefits mobile customers. However, if MNP also causes consumer ignorance, as telephone numbers no...
Persistent link: https://www.econbiz.de/10014028591
Persistent link: https://www.econbiz.de/10001766174
Rising costs in pharmaceutical expenditure have become a major concern for policy makers in Germany over the last years. Therefore the pharmaceutical market in Germany has been increasingly targeted by different kinds of regulations, focussing both on the supply and the demand side, using price,...
Persistent link: https://www.econbiz.de/10010300533